Table of Contents
Hyperparathyroidism – Analysis and Market Forecasts to 2019 Summary The global hyperparathyroidism therapeutics market is forecast to grow to reach $2.6 billion by 2019. This moderate growth is primarily attributed to the increase in the hyperparathyroidism patient population and the expected launches of two novel drugs: CTAP101 and KAI-4169 IV. The major barriers for the hyperparathyroidism therapeutics ma...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
(866) 682 9815
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...
... Outcomes and reduce resistance rates Decreased number of antimicrobial drugs in pipeline from Antimicrobial stewardship, Jamie winner. Management of infectious diseases 32nd annual madison clinical ...
... To target chronic pain market with a novel opioid: Slow rate of entry into cns designed to: Reduce abuse liability Reduce drowsiness Reduce respiratory depression Long-acting profile Properties ...
Reportlinker.com © Copyright 2013. All rights reserved.